Skip to content
OpenCapital
Get started

Milestone Pharmaceuticals MIST Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

Diluted EPS-$0.19Miss by $0.04
EPS estimate-$0.15

Next report

Aug 12, 2026 (in a month)
Revenue estimate$1.1M
EPS estimate-$0.18

Versus estimates

Revenue

Q1 2026$238.0KMiss by $29.9MQ4 2025$1.5MMiss by $36.0M

Diluted EPS

Q1 2026-$0.20Miss by $0.26Q4 2025-$0.16Beat by $0.02Q3 2025-$0.12Beat by $0.05Q2 2025-$0.20Miss by $0.02Q1 2025-$0.31Miss by $0.12
Q4 2024-$0.19Miss by $0.04

Ask the moment Milestone Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Milestone Pharmaceuticals report Q4 2024 earnings?
Milestone Pharmaceuticals (MIST) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Milestone Pharmaceuticals's Q4 2024 revenue and EPS?
Milestone Pharmaceuticals reported diluted EPS of $-0.19 for Q4 2024.
Did Milestone Pharmaceuticals beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.15 by $0.04.
Where can I find Milestone Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-002849) directly on SEC EDGAR. The filing index links above go to sec.gov.